Double Encapsulation of Resveratrol and Doxorubicin in Composite Nanogel—An Opportunity to Reduce Cardio- and Neurotoxicity of Doxorubicin
Abstract
Share and Cite
Radeva, L.; Yordanov, Y.; Spassova, I.; Kovacheva, D.; Tzankova, V.; Yoncheva, K. Double Encapsulation of Resveratrol and Doxorubicin in Composite Nanogel—An Opportunity to Reduce Cardio- and Neurotoxicity of Doxorubicin. Gels 2024, 10, 699. https://doi.org/10.3390/gels10110699
Radeva L, Yordanov Y, Spassova I, Kovacheva D, Tzankova V, Yoncheva K. Double Encapsulation of Resveratrol and Doxorubicin in Composite Nanogel—An Opportunity to Reduce Cardio- and Neurotoxicity of Doxorubicin. Gels. 2024; 10(11):699. https://doi.org/10.3390/gels10110699
Chicago/Turabian StyleRadeva, Lyubomira, Yordan Yordanov, Ivanka Spassova, Daniela Kovacheva, Virginia Tzankova, and Krassimira Yoncheva. 2024. "Double Encapsulation of Resveratrol and Doxorubicin in Composite Nanogel—An Opportunity to Reduce Cardio- and Neurotoxicity of Doxorubicin" Gels 10, no. 11: 699. https://doi.org/10.3390/gels10110699
APA StyleRadeva, L., Yordanov, Y., Spassova, I., Kovacheva, D., Tzankova, V., & Yoncheva, K. (2024). Double Encapsulation of Resveratrol and Doxorubicin in Composite Nanogel—An Opportunity to Reduce Cardio- and Neurotoxicity of Doxorubicin. Gels, 10(11), 699. https://doi.org/10.3390/gels10110699

